Therapeutic Targeting of c-Myc in T-Cell Acute Lymphoblastic Leukemia (T-ALL)

T-ALL patients treated with intensive chemotherapy achieve high rates of remission. However, frequent long-term toxicities and relapses into chemotherapy-refractory tumors constitute major clinical challenges which could be met by targeted therapies. c-MYC is a central oncogene in T-ALL, prompting t...

Descripción completa

Detalles Bibliográficos
Autores principales: Loosveld, Marie, Castellano, Rémy, Gon, Stéphanie, Goubard, Armelle, Crouzet, Thomas, Pouyet, Laurent, Prebet, Thomas, Vey, Norbert, Nadel, Bertrand, Collette, Yves, Payet-Bornet, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102800/
https://www.ncbi.nlm.nih.gov/pubmed/24930440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102800/
https://www.ncbi.nlm.nih.gov/pubmed/24930440

Ejemplares similares